How much is the latest price of capmatinib in 2024?

Capmatinib (Capmatinib) is a targeted drug used to treat advanced or metastatic non-small cell lung cancer (NSCLC), especially for patients who carry MET gene 14 exon skipping mutations. Although Capatinib (Capatinib) was approved by the U.S. Food and Drug Administration (FDA) in 2020, as of 2024, the drug has not yet been launched in mainland China, so domestic patients cannot purchase it through formal channels.

Since Capatinib (Capatinib) is not yet available in China, patients can only purchase it through overseas channels. The original drug is produced by Novartis and is relatively expensive. In foreign countries, the price of original drugs is generally around tens of thousands of yuan, which is a heavy financial burden for many patients. The high price is mainly due to factors such as drug development costs, clinical trial expenses, and brand premiums.

Faced with the high prices of original drugs, some patients choose to purchase foreign generic drugs. Generic drugs produced in Laos have become the choice of many patients because of their low prices and basically the same ingredients as the original drugs. The price of Laos's generic capmatinib is about 3,000 yuan, which makes long-term treatment affordable for more patients.

The quality and efficacy of generic drugs are major concerns for patients. Lao generic drugs have attracted the attention of many patients with their lower prices and pharmaceutical ingredients that are basically the same as the original drugs. Although there may be certain quality differences in the production process of generic drugs, generic drugs in Laos generally undergo strict quality control, which can guarantee the efficacy and safety of the drugs to a certain extent.

Whether you choose the original drug or a generic drug, patients need to be under the guidance of a doctor when using Capatinib (Capatinib) . Common side effects of Capatinib (Capatinib) include peripheral edema, nausea, vomiting, loss of appetite and fatigue. More serious side effects may include interstitial lung disease, liver function damage and hyperglycemia. Therefore, patients need to undergo regular physical examinations and monitor liver function and other physiological indicators to ensure the safety and effectiveness of the drug.